missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ DCAF12L2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA560809
This item is not returnable.
View return policy
Description
Immunogen sequence: RQRQQNIRPL CSREGGTGVR SLSFYQHI Highest antigen sequence identity to the following orthologs: Mouse - 96%, Rat - 93%.
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by Gly-His and Trp-Asp (GH-WD), which may facilitate formation of heterotrimeric or multi-protein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene appears to represent an intronless retrocopy of a related multi-exon gene located on chromosome 9. However, the CDS of this intronless gene remains intact, it is conserved in other mammalian species, it is known to be transcribed, and it is therefore thought to encode a functional protein. [provided by RefSeq, May 2010].
Specifications
| DCAF12L2 | |
| Polyclonal | |
| Unconjugated | |
| DCAF12L2 | |
| DCAF12L2; DDB1 and CUL4 associated factor 12 like 2; DDB1 and CUL4 associated factor 12-like 2; DDB1- and CUL4-associated factor 12-like protein 2; WD repeat-containing protein 40C; WDR40C | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 340578 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.4 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q5VW00 | |
| DCAF12L2 | |
| Recombinant protein corresponding to Human DCAF12L2. Recombinant protein control fragment (Product #RP-99271). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction